Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial
新辅助帕博利珠单抗联合卡铂加多西他赛治疗三阴性乳腺癌的临床和生物标志物结果:NeoPACT II期临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.5033
Sharma, Priyanka; Stecklein, Shane R; Yoder, Rachel; Staley, Joshua M; Schwensen, Kelsey; O'Dea, Anne; Nye, Lauren; Satelli, Deepti; Crane, Gregory; Madan, Rashna; O'Neil, Maura F; Wagner, Jamie; Larson, Kelsey E; Balanoff, Christa; Kilgore, Lyndsey; Phadnis, Milind A; Godwin, Andrew K; Salgado, Roberto; Khan, Qamar J; O'Shaughnessy, Joyce